BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15304365)

  • 21. Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver.
    Lin-Lee YC; Strobl W; Soyal S; Radosavljevic M; Song M; Gotto AM; Patsch W
    J Lipid Res; 1993 Feb; 34(2):249-59. PubMed ID: 8429259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
    Singh JP; Kauffman R; Bensch W; Wang G; McClelland P; Bean J; Montrose C; Mantlo N; Wagle A
    Mol Pharmacol; 2005 Sep; 68(3):763-8. PubMed ID: 15933217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The -700/-310 fragment of the apolipoprotein A-IV gene combined with the -890/-500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV gene.
    Le Beyec J; Chauffeton V; Kan HY; Janvier PL; Cywiner-Golenzer C; Chatelet FP; Kalopissis AD; Zannis V; Chambaz J; Pinçon-Raymond M; Cardot P
    J Biol Chem; 1999 Feb; 274(8):4954-61. PubMed ID: 9988739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of allelic differences at the A-I/C-III/A-IV gene cluster with carotid artery intima-media thickness and plasma lipid transport in hypercholesterolemic-hypertriglyceridemic humans.
    Patsch W; Sharrett AR; Chen IY; Lin-Lee YC; Brown SA; Gotto AM; Boerwinkle E
    Arterioscler Thromb; 1994 Jun; 14(6):874-83. PubMed ID: 8199177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Apolipoprotein A I-C III-A IV deficiency].
    Kato H
    Nihon Rinsho; 1994 Dec; 52(12):3253-6. PubMed ID: 7853719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.
    Gautier T; Masson D; Jong MC; Pais de Barros JP; Duverneuil L; Le Guern N; Deckert V; Dumont L; Bataille A; Zak Z; Jiang XC; Havekes LM; Lagrost L
    Biochem J; 2005 Jan; 385(Pt 1):189-95. PubMed ID: 15339254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interaction between genes and diet as a determinant of the plasma levels of cholesterol].
    López Miranda J; Ordovás JM; Pérez Jiménez F
    Med Clin (Barc); 1998 Oct; 111(14):546-51. PubMed ID: 9859082
    [No Abstract]   [Full Text] [Related]  

  • 28. Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo.
    Rotllan N; Ribas V; Calpe-Berdiel L; Martín-Campos JM; Blanco-Vaca F; Escolà-Gil JC
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):e128-32. PubMed ID: 15994442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein gene expression in the rabbit: abundance, size, and distribution of apolipoprotein mRNA species in different tissues.
    Lenich C; Brecher P; Makrides S; Chobanian A; Zannis VI
    J Lipid Res; 1988 Jun; 29(6):755-64. PubMed ID: 3171395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice.
    Gao J; Wei Y; Huang Y; Liu D; Liu G; Wu M; Wu L; Zhang Q; Zhang Z; Zhang R; Liang C
    J Biol Chem; 2005 Apr; 280(13):12559-66. PubMed ID: 15649902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency.
    Vaessen SF; Veldman RJ; Comijn EM; Snapper J; Sierts JA; van den Oever K; Beattie SG; Twisk J; Kuivenhoven JA
    J Gene Med; 2009 Aug; 11(8):697-707. PubMed ID: 19431216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to a urate-lowering diet according to polymorphisms in the apolipoprotein AI-CIII-AIV cluster.
    Cardona F; Tinahones FJ; Collantes E; Garcia-Fuentes E; Escudero A; Soriguer F
    J Rheumatol; 2005 May; 32(5):903-5. PubMed ID: 15868628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
    Li H; Gu S; Cao X; Wang Z; She M
    Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequences and expression of the porcine apolipoprotein A-I and C-III mRNAs.
    Trieu VN; Hasler-Rapacz J; Rapacz J; Black DD
    Gene; 1993 Jan; 123(2):173-9. PubMed ID: 8428656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.
    Cardona F; Tinahones FJ; Collantes E; Escudero A; García-Fuentes E; Soriguer FJ
    Ann Rheum Dis; 2005 Jan; 64(1):85-8. PubMed ID: 15115711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation patterns of the human apoA-I/C-III/A-IV gene cluster in adult and embryonic tissues suggest dynamic changes in methylation during development.
    Shemer R; Eisenberg S; Breslow JL; Razin A
    J Biol Chem; 1991 Dec; 266(35):23676-81. PubMed ID: 1748645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
    Li H; Gu S; She M
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.
    Nagasawa M; Akasaka Y; Ide T; Hara T; Kobayashi N; Utsumi M; Murakami K
    Biochem Pharmacol; 2007 Dec; 74(12):1738-46. PubMed ID: 17904533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
    Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
    J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.